Parker H. Petit’s commitment will launch a research hub focused on using artificial intelligence to model diseases, identify treatment paths, and move discoveries closer to patient care.

Inspired by the ionic signaling of our nervous system, researchers built sensors and therapeutic devices that can communicate and coordinate with each other through tissue.

Tech Square Tech Hop and Avant South showcase Georgia Tech's leadership in strengthening Atlanta's growing innovation ecosystem.

As artificial intelligence becomes more integrated into healthcare, researchers are exploring its potential to support clinical decision-making, improve mental health interventions, expand access to care, and accelerate medical innovation.

A Georgia Tech student transformed her search to understand her mother's ALS into AI-driven research that could reshape how scientists study neurodegenerative diseases.

While SpudCell is an important milestone in the field, it stops short of being a fully synthetic living cell.

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery.

The science behind the buzz, as told by the guy who stood still.

The honorary society dates to the early days of the United States and honors excellence and contributions that advance society.

AI and machine learning provide new tools for scientists to think about drug discovery.